MEDPLUS

Medplus Health Services Share Price

 

 

Invest in Medplus Health Services with 3.4X leverage

Invest with MTF

Performance

  • Low
  • ₹810
  • High
  • ₹826
  • 52 Week Low
  • ₹642
  • 52 Week High
  • ₹1,045
  • Open Price₹816
  • Previous Close₹814
  • Volume84,673

Investment Returns

  • Over 1 Month + 3.74%
  • Over 3 Month -2.21%
  • Over 6 Month -8.72%
  • Over 1 Year -3.94%

Smart Investing Starts Here Start SIP with Medplus Health Services for Steady Growth!

Invest Now

Medplus Health Services Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 50.2
  • PEG Ratio
  • 0.5
  • Market Cap Cr
  • 9,787
  • P/B Ratio
  • Average True Range
  • 22.1
  • EPS
  • 16.28
  • Dividend Yield
  • 0
  • MACD Signal
  • 6.76
  • RSI
  • 60.25
  • MFI
  • 61.82

Medplus Health Services Financials

Medplus Health Services Technicals

EMA & SMA

Current Price
₹816.80
+ 3.2 (0.39%)
pointer
  • Bearish Moving Average 2
  • Bullish Moving Average 14
  • 20 Day
  • ₹798.93
  • 50 Day
  • ₹795.32
  • 100 Day
  • ₹805.15
  • 200 Day
  • ₹804.61

Resistance and Support

817.52 Pivot Speed
  • R3 841.83
  • R2 833.97
  • R1 825.38
  • S1 808.93
  • S2 801.07
  • S3 792.48

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Medplus Health Services Ltd. is one of India’s largest pharmacy retail chains, offering a wide range of medicines, healthcare products, and diagnostic services. With an extensive network of stores, it provides convenient, affordable healthcare solutions across India.

Medplus Health Services has an operating revenue of Rs. 6,293.02 Cr. on a trailing 12-month basis. An annual revenue growth of 9% is good, Pre-tax margin of 3% needs improvement, ROE of 8% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its key moving averages, around 4% and -0% from 50DMA and 200DMA. It needs to stay above these levels to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 76 which is a FAIR score but needs to improve its earnings, a RS Rating of 63 which is FAIR indicating the recent price performance, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 99 indicates it belongs to a poor industry group of Retail-Drug Stores and a Master Score of B is close to being the best. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock definitely has some strength, you may want to examine it in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Medplus Health Services Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-10-31 Quarterly Results
2025-08-02 Quarterly Results
2025-05-27 Audited Results
2025-01-31 Quarterly Results
2024-11-12 Quarterly Results

Medplus Health Services F&O

Medplus Health Services Shareholding Pattern

40.29%
21.48%
2.24%
16.53%
12.22%
7.24%

Medplus Health Services FAQs

Medplus Health Services share price is ₹816 As on 11 December, 2025 | 04:09

The Market Cap of Medplus Health Services is ₹9787.1 Cr As on 11 December, 2025 | 04:09

The P/E ratio of Medplus Health Services is 50.2 As on 11 December, 2025 | 04:09

The PB ratio of Medplus Health Services is 5.6 As on 11 December, 2025 | 04:09

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23